La chaîne d'options affiche les données clés des options sur actions de Ascentage Pharma Group à différents prix d'exercice et dates d'expiration. Les traders utilisent ces informations pour analyser les transactions potentielles et évaluer le sentiment du marché pour Ascentage Pharma Group..

Ascentage Pharma Group (NASDAQ:AAPG) Stock, Chaîne d'Options

Ascentage Pharma Group

Ascentage Pharma Group International is a clinical-stage biotechnology company engaged in the development and sales of novel small-scale therapies for cancers, hepatitis B virus, or HBV, and certain age-related diseases. It focuses on developing therapies that inhibit protein-protein interactions to restore apoptosis or programmed cell death. The Group has one reportable operating segment, which is discovering, developing, and commercializing therapies to address medical needs in hematological malignancies. The company's geographical segments include the United States and Mainland China.

Ascentage Pharma Group International - American Depository Shares

Ascentage Pharma Group International

ASCENTAGE PHARMA GROUP INTL DS

News

Financing

Press Releases

Ascentage Pharma Announces Pricing of Top-Up Placement

Ascentage Pharma Announces Closing of Placement Shares in Top-Up Placement

Ascentage Pharma to Participate in BTIG Virtual Biotechnology Conference 2025

Health Care

Ascentage Pharma to Participate in Evercore China Biotech Summit

Ascentage Pharma to Report 2025 Six Month Interim Results and Provide Corporate Update on August 20, 2025

Ascentage Pharma Announces Global Registrational Phase III Study of Lisaftoclax for First-line Treatment of Patients with Higher-Risk Myelodysplastic Syndrome Cleared by US FDA and EMA

Earnings

Ascentage Pharma Reports 2025 Interim Unaudited Six Months Financial Results and Business Updates

Ascentage Pharma to Participate in Three Upcoming Investor Conferences in September 2025

Ascentage Pharma to Participate in Three Upcoming Investor Conferences in October 2025

Ascentage Pharma to Participate in Two Upcoming Investor Conferences in November 2025

AAPG

Agios Pharmaceuticals, Inc. - Common Stock

Agios Pharmaceuticals

Alvotech

Apellis Pharmaceuticals, Inc. - Common Stock

Apellis Pharmaceuticals

Arcutis Biotherapeutics, Inc. - Common stock

Arcutis Biotherapeutics

Cidara Therapeutics

Celcuity

CG Oncology

Centessa Pharmaceuticals plc - American Depositary Shares

Centessa Pharmaceuticals

Catalyst Pharmaceuticals, Inc. - Common Stock

Catalyst Pharmaceuticals

Dyne Therapeutics

Amicus Therapeutics

GRAIL

IDEAYA Biosciences

Disc Medicine

Kiniksa Pharmaceuticals, Ltd. - Class A Ordinary Shares

Kiniksa Pharmaceuticals

Jyong Biotech

Mineralys Therapeutics, Inc. - Common Stock

Mineralys Therapeutics

Ultragenyx Pharmaceutical Inc. - Common Stock

Ultragenyx Pharmaceutical

Recursion Pharmaceuticals, Inc. - Class A Common Stock

Recursion Pharmaceuticals

Scholar Rock Holding Corporation - Common Stock

Scholar Rock Holding

Telix Pharmaceuticals Limited - American Depositary Shares

Telix Pharmaceuticals

Travere Therapeutics, Inc. - Common Stock

Travere Therapeutics

Veracyte

Xenon Pharmaceuticals Inc. - Common Shares

Xenon Pharmaceuticals

Zai Lab Limited - American Depositary Shares

Comments

Ascentage Pharma Group

Ascentage Pharma Group (AAPG) Options

No option chain data available. Please try again later

Notizie

PARTENAIRE / CONTRIBUTEUR

BENZINGA MONDIAL